Autoimmune Learning Network is a digital network providing information on innovations in care for patients with autoimmune diseases, published by HMP Global.
Patients with #IMIDs on B cell-depleting therapies were more at risk from infections resulting from #COVID19. #Coronavirus
Read more:
https://t.co/hTqXkSNkJm
Don't miss this conversation on how race, ethnicity, age, sexual identity & orientation, and socioeconomic status can affect access to care for patients with #SystemicLupusErythematosus, with @alhkim, @ashira_md, and, @jrose1282 .
Listen now:
https://t.co/wWsOiZ3AtF
Dr Liew (@rheum_cat) discusses how stress and anxiety may predict patient-reported disease activity in #AxialSponyloarthritis, and how to best care for these patients during high-stress times. #axSpA
Listen here:
https://t.co/XCPH4ZPrnR
Check in with @AlexisOgdie to learn about the combined goals that combined clinics can achieve for patients with #autoimmune disorders.
Watch the video here:
https://t.co/6wkWiDPbIi
Uncertainty related to illness can have a negative impact on patients' mental health. #SystemicAutoimmuneRheumaticDiseases
Read more here:
https://t.co/vJmHWrBdfk
Check in with Dr Petri on how to improve #lupus outcomes by individualizing care. #SystemicLupusErythematosus
Watch the 6-minute video here:
https://t.co/QNvT6ohN7w
At #IAS2022, Dr Cassandra Calabrese (@CCalabreseDO) went over the #vaccination recommendations for patients with #IMIDs, including for the #COVID vaccination.
For her advice, read here:
https://t.co/ZkOAyjRUvb
Dr Hudesman (@DavidHudesmanMD) reviews his talk from #IAS2022 on emerging challenges in managing patients with #IBD and the promise of S1P receptor modulators. #Gastroenterology
Watch here:
https://t.co/L9ieiM43vr
When discussing the management of immune-related adverse events at #IAS2022, Dr Calabrese (@LCalabreseDO) stressed an interdisciplinary approach. #oncology#irAE
Read more here:
https://t.co/AP7blJYq28
At #IAS2022, @DrJoelGelfand shared some news about the number of #JAKinhibitors that are currently in development for the treatment of #IMIDs
Read more here:
https://t.co/ltk461unc7
Dr Petri presented at #IAS2022 about the importance of providing individualized care for patients with #SystemicLupusErythematosus.
Watch her 6-minute recap here:
https://t.co/10EkyFd2m9
Dr Malter discussed steps to take to reduce health inequities and disparities in care affecting patients with #IMIDs at #IAS2022.
Read more about her advice here:
https://t.co/MskINciyPV
Dr Merola (@JosephMerolaMD) covered how to overcome the challenges with #PsoriaticArthritis in his presentation at #IAS2022.
Read about his recommendations here:
https://t.co/3JCNwy6Ckj
At #IAS2022, Dr Calabrese (@LCalabreseDO) stressed that preventing and effectively treating #COVID19 among immunocompromised patients is vitally important.
Read here for his strategies for managing these patients:
https://t.co/ox9ACNlOWW
From #IAS2022 — Don't miss Dr Hanauer's (@NMH_SHanauerMD) immunologic lessons from #COVID19 about risks to and care of patients with #IBD.
Watch his recap here:
https://t.co/GyKoJ12mz1
In the keynote speech at #IAS2022 addressing the changes #COVID has brought, Michael Osterholm said, "We don’t know what the next shoe might be that will drop. We have to prepare for the possibilities.”
Read more:
https://t.co/qjqqLk3Z5F
In a discussion-based session at #IAS2022, Drs Merola (@JosephMerolaMD) and Cheifetz shared insights on achieving remission in #IMIDs.
Read further:
https://t.co/vTdaVbN0HI